Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the unaudited standalone & consolidated financial results for the third quarter and nine months ended December 31, 2025.
Titan Biotech Limited Press Release Feb 03 2026
Filed with BSE · · 1 page · English
Release
Story so far
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Jan 07 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Titan Biotech Limited Press Release Jan 02 2026
- Intimation Of Record Date For Sub Division / Split Of Equity Shares Of The Company
- Titan Biotech Limited Press Release Dec 31 2025
Later from Titan Biotech
- SEBI Circular Dated 30Th January 2026 On Ease Of Doing Investment - Special Window For Transfer And Dematerialisation Of Physical SecuritiesSpecial Window For Transfer And Dematerialisation Of Physical Securities
- Titan Biotech Limited Press Release Feb 05 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release Feb 06 2026
- Announcement Regarding New ISIN Activation Letter From Depositories For Sub-Division Of Equity Share Of The Company
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech